This survey seeks to understand your participation with your healthcare provider regarding decision-making about afib stroke prevention. To participate in this anonymous survey, you must have afib, be at least 18 years old, live in the United States, and be contemplating a decision about afib stroke prevention treatment, or have made a decision on that …
Read More
As you're probably aware, the annual Get in Rhythm. Stay in Rhythm.TM Atrial Fibrillation Patient Conference is this September 16-18 in Dallas, Texas. You may not know that we recently confirmed Elaine Hylek, MD, Professor of Medicine and Director of the Thrombosis & Anticoagulation Service at Boston University Medical Center, and one of the world's …
Read More
We just put up a blog post over at MyAFibExperience.org, a site co-developed by American Heart Association and StopAfib.org. The post shares some of the information on blood thinners and prevention of afib-related strokes that we gleaned from the recent 2016 Atrial Fibrillation Symposium in Orlando. We hope these nuggets are good food for thought …
Read More
Here's an important article about the Lariat device for closing off the left atrial appendage. Back in March, we reported from the American College of Cardiology that Dr. Natale's group had reported finding that about one-fourth of Lariat patients had leaks (see bottom of page), some with bad results such as strokes. This new article tells …
Read More
Set your DVRs, or watch live, on Saturday, March 23, at 8AM ET/PT, as the Discovery Channel unveils the atrial fibrillation documentary, “A Heartbeat Away From Stroke”. StopAfib.org was thrilled to collaborate with Discovery Channel and other organizations on this documentary. Learn more at StopAfib.org Collaborates on Discovery Channel Atrial Fibrillation Documentary
Read More
Press Release: Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS® (apixaban) Friday, December 28, 2012 5:46 pm EST PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved ELIQUIS® (apixaban). Please see full Prescribing Information including BOXED WARNING and Medication Guide …
Read More
Action for Stroke Prevention, an alliance of renowned health experts and patient organizations, has published new reports calling for policy makers and the medical and patient communities to join forces to prevent atrial fibrillation-related strokes. Learn more at: New Report Confirms Europe is on the Brink of a Stroke Crisis
Read More
The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and …
Read More
At Heart Rhythm 2012, Dr. Albert Waldo shared with StopAfib.org’s Mellanie True Hills about why aspirin should no longer be used for the prevention of stroke in atrial fibrillation. Dr. Waldo noted that many global afib guidelines have been revised, or soon will be, to remove aspirin as a recommended atrial fibrillation stroke prevention treatment. …
Read More
In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …
Read More